The Advisory Committee on Medicines Scheduling has proposed downscheduling emergency contraceptive medication ulipristal, on the same basis as the current scheduling of levonorgestrel.
The committee has advised an implementation date of 01 Feb 2017 for the move, with the delegate to the Secretary of the Department of Health agreeing with the advice, subject to a consultation period.
The delegate has also issued a draft decision in favour of doubling the S2 pack size of fexofenadine for seasonal allergic rhinitis to 20 dosage units and not more than ten days' supply.
Other scheduling proposals subject to consultation include changes to 2,4 dinitrophenol and N,N-dimethyltrypamine, while a proposal to change the scheduling of piper methysticum (kava) was not accepted.
The consultation period on the interim decisions closes on 29 Sep - for details see www.tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 16
